|Day Low/High||101.94 / 101.99|
|52 Wk Low/High||58.50 / 101.99|
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will voluntarily withdraw the contingent value rights (CVRs) it issued under a Contingent Value Rights Agreement dated October 24, 2013 (CVR Agreement)...
Shire has cash for what could be a $5 billion deal, but treatment base is limited.
And stop chasing stocks that won't let you in.
Trade-Ideas LLC identified Cubist Pharmaceuticals (CBST) as a pre-market leader candidate
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) announced today the U.
Trade-Ideas LLC identified Cubist Pharmaceuticals (CBST) as a momo momentum candidate
Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender to purchase all outstanding shares of common stock of Cubist Pharmaceuticals, Inc.
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cubist Pharmaceuticals
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cubist...
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Cubist Pharmaceuticals, Inc.
Levi & Korsinsky is investigating the Board of Directors of Cubist Pharmaceuticals, Inc.
In 2014 drugmakers long on cash but short on growth bought quick access to markets that would have otherwise taken years to build. Can this continue?
Shares of Merck are tumbling after a Delaware court denied Cubist's bid to stop Hospira from selling a generic version of Cubicin in 2016.
Cubist Pharmaceutical (CBST) shares declined after a judge revoked all but one of the patents on the company's highest selling drug treatment.
Investing in safer hospital stays.
Trade-Ideas LLC identified Cubist Pharmaceuticals (CBST) as a "perilous reversal" (up big yesterday but down big today) candidate
The recent selloff means it's time to buy Disney, Starbucks, Nike and Enbridge, Cramer says.
Not only do all three have impressive growth, but they benefit from falling oil prices, Cramer says.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the U.
Oil prices were a sinking ship on Monday, capsizing energy stocks and almost everything else caught in their wake.
Plunging crude oil prices and a selloff in energy stocks are weighing on benchmark indices again on Monday, limiting potential gains spurred by a rally among pharmaceuticals.